SAN DIEGO--(BUSINESS WIRE)--Critical Diagnostics announced today that results of a University Hospital Basel study of just over 200 acute heart failure patients followed over a three-and-a-half year period, showed that testing of the cardiac biomarker ST2 in-hospital may help to identify a high-risk population with particular benefit from tailored therapy at discharge.
Help employers find you! Check out all the jobs and post your resume.
